C Luongo

614 total citations
19 papers, 490 citations indexed

About

C Luongo is a scholar working on Pharmacology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C Luongo has authored 19 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C Luongo's work include Medical and Biological Ozone Research (8 papers), Diabetic Foot Ulcer Assessment and Management (4 papers) and Peripheral Artery Disease Management (4 papers). C Luongo is often cited by papers focused on Medical and Biological Ozone Research (8 papers), Diabetic Foot Ulcer Assessment and Management (4 papers) and Peripheral Artery Disease Management (4 papers). C Luongo collaborates with scholars based in Italy and Japan. C Luongo's co-authors include Ludovico Coppola, A. Sammartino, Riccardo E. Giunta, M Scafuro, A Grassia, Francesco Imperatore, Luigi Mascolo, A Tirelli, Amelia Filippelli and Antonio Coppola and has published in prestigious journals such as Critical Care Medicine, European Journal of Pharmacology and Intensive Care Medicine.

In The Last Decade

C Luongo

17 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Luongo Italy 12 299 192 79 69 62 19 490
J Siggaard-Andersen Denmark 11 83 0.3× 120 0.6× 21 0.3× 81 1.2× 44 0.7× 37 452
Hayal Güler Türkiye 13 48 0.2× 58 0.3× 21 0.3× 64 0.9× 33 0.5× 36 530
Alberto Biestro Uruguay 16 31 0.1× 93 0.5× 14 0.2× 21 0.3× 120 1.9× 41 661
Shu‐Mien Chuang Taiwan 17 112 0.4× 88 0.5× 7 0.1× 46 0.7× 151 2.4× 40 749
Ceylan Ayada Türkiye 12 92 0.3× 90 0.5× 5 0.1× 82 1.2× 41 0.7× 35 480
Nicole de Talancé France 12 60 0.2× 82 0.4× 32 0.4× 118 1.7× 41 0.7× 24 517
Jürgen Bachmann Germany 12 94 0.3× 70 0.4× 6 0.1× 84 1.2× 40 0.6× 18 640
Nelson E. Sessler United States 13 31 0.1× 49 0.3× 23 0.3× 144 2.1× 163 2.6× 18 835
Burton B. Silver United States 13 12 0.0× 46 0.2× 34 0.4× 55 0.8× 89 1.4× 16 595
Arkadiusz Derkacz Poland 13 47 0.2× 85 0.4× 2 0.0× 62 0.9× 75 1.2× 68 513

Countries citing papers authored by C Luongo

Since Specialization
Citations

This map shows the geographic impact of C Luongo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Luongo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Luongo more than expected).

Fields of papers citing papers by C Luongo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Luongo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Luongo. The network helps show where C Luongo may publish in the future.

Co-authorship network of co-authors of C Luongo

This figure shows the co-authorship network connecting the top 25 collaborators of C Luongo. A scholar is included among the top collaborators of C Luongo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Luongo. C Luongo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Coppola, Serena, C Luongo, Roberto Russo, et al.. (2025). The Beneficial Effects of a N-(1-Carbamoyl-2-phenyl-ethyl) Butyramide on Human Keratinocytes. Pharmaceuticals. 18(4). 517–517.
2.
3.
Marfella, Raffaele, C Luongo, Antonio Coppola, et al.. (2009). Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients. Atherosclerosis. 208(2). 473–479. 28 indexed citations
4.
Filippo, Clara Di, Carmela Cervone, Cláudia Rossi, et al.. (2009). Antiarrhythmic effect of acute oxygen-ozone administration to rats. European Journal of Pharmacology. 629(1-3). 89–95. 12 indexed citations
5.
Coppola, Ludovico, et al.. (2009). Ozonized autohaemotransfusion could be a potential rapid‐acting antidepressant medication in elderly patients. International Journal of Geriatric Psychiatry. 25(2). 208–213. 8 indexed citations
6.
Filippo, C. Di, Raffaele Marfella, Franca Ferraraccio, et al.. (2008). Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct. Inflammation Research. 57(10). 445–449. 41 indexed citations
7.
Luongo, C, Catia Giordano, M Scafuro, et al.. (2008). A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice. European Journal of Pharmacology. 603(1-3). 42–49. 68 indexed citations
8.
Coppola, Antonio, Ludovico Coppola, C Luongo, et al.. (2007). Ozonized autohemotransfusion does not affect arterial vasodilation in patients with peripheral arterial disease. International Journal of Angiology. 16(1). 7–11. 5 indexed citations
9.
Imperatore, Francesco, Salvatore Cuzzocrea, C Luongo, et al.. (2004). Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome. Intensive Care Medicine. 30(6). 1175–1181. 28 indexed citations
10.
Coppola, Ludovico, B Lettieri, Daniel Cozzolino, et al.. (2002). Ozonized autohaemotransfusion and fibrinolytic balance in peripheral arterial occlusive disease. Blood Coagulation & Fibrinolysis. 13(8). 671–681. 10 indexed citations
11.
Giunta, Riccardo E., Antonio Coppola, C Luongo, et al.. (2001). Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Annals of Hematology. 80(12). 745–748. 93 indexed citations
12.
Cuzzocrea, Salvatore, Francesco Imperatore, Giuseppina Costantino, et al.. (2000). ROLE OF HYPERBARIC OXYGEN EXPOSURE IN REDUCTION OF LIPID PEROXIDATION AND IN MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN ADMINISTRATION IN THE RAT. Shock. 13(3). 197–203. 29 indexed citations
13.
Luongo, C, Francesco Imperatore, Adone Baroni, et al.. (1999). Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa.. PubMed. 26(1). 21–5. 13 indexed citations
14.
Luongo, C, Francesco Imperatore, Salvatore Cuzzocrea, et al.. (1998). Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Critical Care Medicine. 26(12). 1972–1976. 59 indexed citations
15.
Luongo, C, et al.. (1996). [Effects of hyperbaric oxygenation in skin and pulmonary infections caused by Pseudomonas aeruginosa].. PubMed. 62(9). 281–7. 2 indexed citations
16.
Coppola, Ludovico, Riccardo E. Giunta, G Verrazzo, et al.. (1995). Influence of ozone on haemoglobin oxygen affinity in type-2 diabetic patients with peripheral vascular disease: in vitro studies.. PubMed. 21(4). 252–5. 18 indexed citations
17.
Verrazzo, G, Ludovico Coppola, C Luongo, et al.. (1995). Hyperbaric oxygen, oxygen-ozone therapy, and rheologic parameters of blood in patients with peripheral occlusive arterial disease.. PubMed. 22(1). 17–22. 48 indexed citations
18.
Luongo, C, et al.. (1992). [Hyperbaric oxygen therapy in the treatment of benign intracranial hypertension. Follow-up of a preliminary study].. PubMed. 58(4 Suppl 1). 97–8. 4 indexed citations
19.
Ruocco, Vincenzo, et al.. (1986). Hyperbaric oxygen treatment of toxic epidermal necrolysis.. PubMed. 38(4). 267–71. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Siggaard-Andersen Breakdown of academic impact, for papers by Hayal Güler Breakdown of academic impact, for papers by Alberto Biestro Breakdown of academic impact, for papers by Shu‐Mien Chuang Breakdown of academic impact, for papers by Ceylan Ayada Breakdown of academic impact, for papers by Nicole de Talancé Breakdown of academic impact, for papers by Jürgen Bachmann Breakdown of academic impact, for papers by Nelson E. Sessler Breakdown of academic impact, for papers by Burton B. Silver Breakdown of academic impact, for papers by Arkadiusz Derkacz
Rankless by CCL
2026